The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1365
Capsaicin Patch (Qutenza) for Postherpetic Neuralgia
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Capsaicin Patch (Qutenza) for Postherpetic Neuralgia
The FDA has approved a topical 8% patch formulation of capsaicin (Qutenza – NeurogesX), available only by prescription, for local treatment of postherpetic neuralgia. Postherpetic neuralgia occurs after herpes zoster in about one third of...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Capsaicin Patch (Qutenza) for Postherpetic Neuralgia
Article code: 1365c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.